Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health.

JCO precision oncology - 1 Jan 2021

Williams P Mickey, Forbes Thomas, P Lund Steven, Cole Kenneth D, He Hua-Jun, Karlovich Chris, Paweletz Cloud P, Stetson Daniel, Yee Laura M, Connors Dana E, Keating Susan M, Destenaves Benoit, Cleveland Megan H, Lau Christie J, Barrett J Carl, Kelloff Gary J, McCormack Robert T

Abstract excerpt

We report the results from a Foundation for the National Institutes of Health Biomarkers Consortium project to address the absence of well-validated quality control materials (QCMs) for circulating tumor DNA (ctDNA) testing. This absence is considered a cause of variance and inconsistencies in translating ctDNA results into clinical actions. METHODS: In this phase I study, QCMs with 14 clinically relevant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to High-Throughput Nucleotide Sequencing

Share to National Institutes of Health (U.S.)

Share to Neoplasms

Share to Quality Control

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 34250423
DOI: 10.1200/PO.20.00528
PMCID: PMC8232894

Genes

ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health.PMID 34250423Read ↗

Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity.Semantic proximity Read ↗

Development of a nine-variant reference material panel to standardize cell-free DNA detection.Semantic proximity Read ↗

Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring.Semantic proximity Read ↗

Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends.Semantic proximity Read ↗

Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA WorkshopSemantic proximity Read ↗

Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.Semantic proximity Read ↗

External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.Semantic proximity Read ↗

Development and characterization of nucleosomal DNA-based reference materials for the epidermal growth factor receptor gene liquid biopsy.Semantic proximity Read ↗

Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA.Semantic proximity Read ↗

Advancing quality-control for NGS measurement of actionable mutations in circulating tumor DNASemantic proximity Read ↗

Droplet digital PCR-based EGFR mutation detection with an internal quality control index to determine the quality of DNA.Semantic proximity Read ↗

Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA MeasurementsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.